The biotechnology company, Blis Technologies, has been censured by the Markets Disciplinary Tribunal and fined 30-thousand dollars for failing to share information with the market that did materially impact its share price.
The biotechnology company, Blis Technologies, has been censured by the Markets Disciplinary Tribunal and fined 30-thousand dollars for failing to share information with the market that did materially impact its share price.